SEI Investments
NUVB icon

SEI Investments’s Nuvation Bio NUVB Stock Holding History

SEI Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Sell
43,203
-40,963
-49% -$228K ﹤0.01% 2991
2025
Q4 		$754K Buy
84,166
+69,302
+466% +$429K ﹤0.01% 2316
2025
Q3 		$55K Buy
+14,864
New +$40.5K ﹤0.01% 2771

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SEI Investments's NUVB Position: Q1 2026 in Review

SEI Investments reduced its Nuvation Bio (NUVB) stake by 49% in Q1 2026, selling an estimated $228K and leaving 43,203 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #2991.

SEI Investments first reported a position in NUVB in Q3 2025 and has held it in 3 quarters since. The position peaked at $754K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • SEI Investments held 43,203 shares of Nuvation Bio worth $185K as of Q1 2026.
  • SEI Investments sold 40,963 Nuvation Bio shares in Q1 2026, an estimated $228K.
  • Nuvation Bio made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2991 holding.
  • SEI Investments first reported a position in Nuvation Bio in Q3 2025 and has held it in 3 quarters since.
  • SEI Investments's Nuvation Bio position peaked at $754K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.